Role of Helicobacter pylori serology in atrophic body gastritis after eradication treatment

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 3, 2002, Pages 507-514

  Lahner, E ^a   Bordi, C ^b   Di Giulio, E ^a   Caruana, P ^b   D'Ambra, G ^a   Milione, M ^b   Grossi, C ^a   Delle Fave, G ^a   Annibale, B ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BISMUTH; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; ERADICATION THERAPY; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; SEROLOGY; STOMACH BIOPSY;

ACUTE DISEASE; ADULT; AGED; ANTACIDS; ANTI-BACTERIAL AGENTS; BISMUTH; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; SEROLOGIC TESTS; TIME FACTORS;

EID: 0036188780     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01213.x     Document Type: Article

References (30)

1. Mucosal inflammation and disease in Helicobacter pylori infection
2. Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia
3. Immune and inflammatory responses to Helicobacter pylori infection
4. The components of gastritis. Histology and pathogenesis
5. Changes in the gastric mucosa following eradication of Helicobacter pylori
6. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients
7. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori
8. Campylobacter pylori antibodies in humans
9. Accurate diagnosis of Helicobacter pylori. Serologic testing
10. Diagnosis of Helicobacter pylori infection
11. Accuracy of invasive and non-invasive tests to diagnose Helicobacter pylori infection
12. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection
13. Accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication
14. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study
15. Long-term sequelae of Helicobacter pylori gastritis
16. Atrophic body gastritis: Distinct features associated with Helicobacter pylori infection
17. Other types of gastritis and gastropathies
18. Helicobacter pylori serology in chronic gastritis with antral atrophy and negative histology for Helicobacter-like organism
19. Helicobacter pylori infection and atrophic gastritis in the elderly
20. IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients
21. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis
22. Helicobacter pylori infection and chronic gastric acid hyposecretion
23. Two thirds of patients with atrophic body gastritis have evidence of Helicobacter pylori infection
24. Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis
25. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: When should it be done?
26. Zollinger Ellison syndrome and antral G-cell hyperfunction in patients with resistant duodenal ulcer disease
27. Classification and grading of gastritis. The updated Sydney system
28. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori
29. Increasing prevalence of Helicobacter pylori infection with age: Continuous risk of infection in adults rather than cohort effect
30. Topics in Helicobacter pylori infection: Focus on a 'search-and-treat' strategy for ulcer disease